Bio-Techne Corporation 2025-2026 Proxy Voting Records

Description as filed by funds: Elections of Directors: Alpna Seth

Bio-Techne Corporation’s own tally for this item (“Elect Director: Alpna Seth”): 134,628,283 for, 5,957,489 against, per its Form 8-K filed November 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 2 – The shareholders elected each of the nominees to the Board of Directors: Each nominee was elected by a majority voting standard defined in the Amended and Restated Articles of Incorporation.”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 150 asset managers below reported 69,265,093 for, 1,187,551 against, 39,484 abstained, 121 not voted.

Showing the 25 largest of 150 asset managers. See all 150 in the interactive database.

Description as filed by funds: Elections of Directors: Amy E. Herr

Bio-Techne Corporation’s own tally for this item (“Elect Director: Amy Herr”): 139,257,947 for, 1,323,873 against, per its Form 8-K filed November 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 2 – The shareholders elected each of the nominees to the Board of Directors: Each nominee was elected by a majority voting standard defined in the Amended and Restated Articles of Incorporation.”
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 150 asset managers below reported 70,451,664 for, 980 against, 39,484 abstained, 121 not voted.

Showing the 25 largest of 150 asset managers. See all 150 in the interactive database.

Description as filed by funds: Elections of Directors: John L. Higgins

Bio-Techne Corporation’s own tally for this item (“Elect Director: John L. Higgins”): 135,131,210 for, 5,460,347 against, per its Form 8-K filed November 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 2 – The shareholders elected each of the nominees to the Board of Directors: Each nominee was elected by a majority voting standard defined in the Amended and Restated Articles of Incorporation.”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 150 asset managers below reported 70,283,352 for, 169,292 against, 39,484 abstained, 121 not voted.

Showing the 25 largest of 150 asset managers. See all 150 in the interactive database.

Description as filed by funds: Elections of Directors: Joseph D. Keegan

Bio-Techne Corporation’s own tally for this item (“Elect Director: Joseph D. Keegan”): 136,272,153 for, 4,315,695 against, per its Form 8-K filed November 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 2 – The shareholders elected each of the nominees to the Board of Directors: Each nominee was elected by a majority voting standard defined in the Amended and Restated Articles of Incorporation.”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 150 asset managers below reported 70,449,069 for, 3,575 against, 39,484 abstained, 121 not voted.

Showing the 25 largest of 150 asset managers. See all 150 in the interactive database.

Description as filed by funds: Elections of Directors: Judith Klimovsky

Bio-Techne Corporation’s own tally for this item (“Elect Director: Judith Klimovsky”): 138,104,299 for, 2,120,409 against, per its Form 8-K filed November 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 2 – The shareholders elected each of the nominees to the Board of Directors: Each nominee was elected by a majority voting standard defined in the Amended and Restated Articles of Incorporation.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 150 asset managers below reported 70,449,072 for, 3,572 against, 39,484 abstained, 121 not voted.

Showing the 25 largest of 150 asset managers. See all 150 in the interactive database.

Description as filed by funds: Elections of Directors: Julie L. Bushman

Bio-Techne Corporation’s own tally for this item (“Elect Director: Julie L. Bushman”): 136,076,243 for, 4,511,497 against, per its Form 8-K filed November 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 2 – The shareholders elected each of the nominees to the Board of Directors: Each nominee was elected by a majority voting standard defined in the Amended and Restated Articles of Incorporation.”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 150 asset managers below reported 70,451,661 for, 983 against, 39,484 abstained, 121 not voted.

Showing the 25 largest of 150 asset managers. See all 150 in the interactive database.

Description as filed by funds: Elections of Directors: Kim Kelderman

Bio-Techne Corporation’s own tally for this item (“Elect Director: Kim Kelderman”): 139,472,895 for, 1,087,500 against, per its Form 8-K filed November 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 2 – The shareholders elected each of the nominees to the Board of Directors: Each nominee was elected by a majority voting standard defined in the Amended and Restated Articles of Incorporation.”
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 150 asset managers below reported 70,451,664 for, 979 against, 39,484 abstained, 121 not voted.

Showing the 25 largest of 150 asset managers. See all 150 in the interactive database.

Description as filed by funds: Elections of Directors: Robert V. Baumgartner

Bio-Techne Corporation’s own tally for this item (“Elect Director: Robert V. Baumgartner”): 134,015,677 for, 6,570,465 against, per its Form 8-K filed November 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 2 – The shareholders elected each of the nominees to the Board of Directors: Each nominee was elected by a majority voting standard defined in the Amended and Restated Articles of Incorporation.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 150 asset managers below reported 70,247,254 for, 205,390 against, 39,484 abstained, 121 not voted.

Showing the 25 largest of 150 asset managers. See all 150 in the interactive database.

Description as filed by funds: Elections of Directors: Rupert Vessey

Bio-Techne Corporation’s own tally for this item (“Elect Director: Rupert Vessey”): 137,441,139 for, 3,145,646 against, per its Form 8-K filed November 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 2 – The shareholders elected each of the nominees to the Board of Directors: Each nominee was elected by a majority voting standard defined in the Amended and Restated Articles of Incorporation.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 150 asset managers below reported 70,451,662 for, 982 against, 39,484 abstained, 121 not voted.

Showing the 25 largest of 150 asset managers. See all 150 in the interactive database.

Description as filed by funds: To set the number of Directors at nine.

Bio-Techne Corporation’s own tally for this item (“1. The shareholders voted to set the number of directors at nine”): 140,278,598 for, 314,005 against, per its Form 8-K filed November 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 150 asset managers below reported 70,452,644 for, 39,484 abstained, 121 not voted.

Showing the 25 largest of 150 asset managers. See all 150 in the interactive database.

Description as filed by funds: Approve, on an advisory basis, the compensation of our executive officers.

Bio-Techne Corporation’s own tally for this item (“3. A non-binding resolution approving the compensation of the Company's named executive officers, as described in the Proxy Statement”): 100,792,824 for, 39,025,321 against — passed, per its Form 8-K filed November 5, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal No. 3 – The shareholders adopted a non-binding resolution approving the compensation of the Company's named executive officers, as described in the Proxy Statement:”
Support: 72% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of Bio-Techne Corporation’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Advisory Vote to Ratify Named Executive Officers' Compensation” (18 managers, Fund and manager reports combined; may count the same shares twice; no share total shown); “14A Executive Compensation” (8 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 145 managers: 55,751,244 for, 13,967,477 against, 475,482 abstained, 121 not voted. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 468 managers: 62,350,371 for, 29,339,448 against, 253,586 abstained, 32,225 not voted. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: Ratify the appointment of KPMG, LLP as the Company's independent registered public accounting firm for the 2026 fiscal year.

Bio-Techne Corporation’s own tally for this item (“4. The appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2026”): 137,578,559 for, 3,055,503 against — passed, per its Form 8-K filed November 5, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal No. 4 – The shareholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2026.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 151 asset managers below reported 70,490,345 for, 18,659 against, 5,000 abstained, 121 not voted.

Showing the 25 largest of 151 asset managers. See all 151 in the interactive database.